BNY Mellon U.S. Equity Income Fund GBP W IncRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -6.4 | 30.8 | 16.1 | 3.3 | 9.6 | |
+/-Cat | -6.1 | 4.2 | 11.2 | -0.1 | 1.6 | |
+/-B’mrk | -3.0 | - | 5.7 | 3.8 | -0.1 | |
Category: US Equity Income | ||||||
Category Benchmark: Morningstar US High Div Yld... |
Key Stats | ||
NAV 16/04/2024 | GBP 1.60 | |
Day Change | -0.41% | |
Morningstar Category™ | US Equity Income | |
IA (formerly IMA) Sector | North America | |
ISIN | IE00BD5M7551 | |
Fund Size (Mil) 28/03/2024 | USD 527.57 | |
Share Class Size (Mil) 16/04/2024 | GBP 8.91 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 15/02/2023 | 0.88% |
Investment Objective: BNY Mellon U.S. Equity Income Fund GBP W Inc |
The Sub-Fund aims to maximise total returns from income and capital growth. The Sub-Fund invests primarily (meaning at least two-thirds of the Sub-Fund's Net Asset Value) in equity and equity-related securities (common and preferred stock, American depositary receipts and global depository receipts (collectively “Depositary Receipts”), listed real estate investment trusts (“REITs”) and master limited partnerships (“MLPs”)), issued by “large-capitalisation companies” located in the U.S. The term “large-capitalisation companies” shall be taken to include securities of companies which, at the time of purchase, have a market capitalisation of US$2 billion or above. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Bailer 17/01/2017 | ||
Brian Ferguson 17/01/2017 | ||
Click here to see others | ||
Inception Date 17/01/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | Morningstar US High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon U.S. Equity Income Fund GBP W Inc | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
JPMorgan Chase & Co | Financial Services | 4.66 |
Medtronic PLC | Healthcare | 4.11 |
AT&T Inc | Communication Services | 3.63 |
AbbVie Inc | Healthcare | 3.42 |
CRH PLC | Basic Materials | 3.35 |
Increase Decrease New since last portfolio | ||
BNY Mellon U.S. Equity Income Fund GBP W Inc |